tradingkey.logo
tradingkey.logo
Search

Cartesian Therapeutics Inc

RNAC
Add to Watchlist
7.920USD
-0.210-2.58%
Close 07-23 16:00ETQuotes delayed by 15 min
226.07MMarket Cap
LossP/E TTM

RNAC Financials

See Cartesian Therapeutics Inc's financials through an all-in-one data dashboard designed for smart investors. This provides you with financial analysis by organizing complex financial statements into customizable views. Access the latest annual financial report or break down performance quarter-by-quarter using the income statement, balance sheet, and cash flow statement. With real-time financial indicators at your fingertips, monitoring a company's market health over time has never been easier.

Cartesian Therapeutics Inc Earnings Date

Latest Release
Apr 30, 2026
EPS / Forecast
-1.46/-0.88
Revenue / Forecast
78.00K/99.83K
Period
FY2025 Earnings
Revenue(YoY)
2.80M
-92.81%
EPS(YoY)
-5.02
-11.95%
Analyst Rating
BUY
2026/07/23
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
Financial Indicators
EPS
-113.40%-1.46
-782.65%-3.56
-22.59%-1.38
-11.36%0.51
99.78%-0.68
99.01%-0.40
35.44%-1.13
125.86%0.58
-7332.58%-315.00
-3621.31%-40.65
---1.74
---2.23
---4.24
--1.15
--6.23
----
----
----
----
----
Revenue
-92.91%78.00K
1129.87%947.00K
16.80%452.00K
-99.11%298.00K
-81.16%1.10M
-99.07%77.00K
-94.09%387.00K
537.17%33.45M
-1.65%5.84M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
-43.90%16.80M
-15.22%20.71M
99.73%39.27M
207.68%34.00M
150.50%29.94M
425.76%24.43M
--19.66M
Net Profit
-121.24%-39.18M
-802.92%-92.58M
-48.46%-35.90M
37.70%13.26M
68.83%-17.71M
94.23%-10.25M
-168.64%-24.18M
184.55%9.63M
-162.31%-56.82M
-3114.73%-177.66M
-14.05%-9.00M
-232.39%-11.39M
-175.28%-21.66M
-51.85%5.89M
55.89%-7.89M
88.41%8.60M
217.00%28.78M
179.24%12.24M
-83.92%-17.89M
118.96%4.56M
Net Margin
-3020.08%-50233.33%
26.58%-9775.71%
-27.11%-7942.92%
12786.02%5330.87%
-65.47%-1610.00%
-519.54%-13315.58%
-4447.45%-6248.84%
119.07%41.37%
-166.71%-973.01%
-6225.38%-2149.26%
---137.41%
---216.94%
---364.82%
--35.09%
--31.37%
----
----
----
----
----
Gross Margin
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
0.00%100.00%
--100.00%
--100.00%
--100.00%
--100.00%
--100.00%
----
----
----
----
----
Debt to assets ratio
----
----
----
----
----
----
----
----
----
-100.00%0.00%
--0.00%
--17.22%
--16.99%
--15.83%
--14.64%
----
----
----
----
----
Revenue
-92.91%78.00K
1129.87%947.00K
16.80%452.00K
-99.11%298.00K
-81.16%1.10M
-99.07%77.00K
-94.09%387.00K
537.17%33.45M
-1.65%5.84M
-50.78%8.27M
-68.37%6.55M
-86.63%5.25M
-82.53%5.94M
-43.90%16.80M
-15.22%20.71M
99.73%39.27M
207.68%34.00M
150.50%29.94M
425.76%24.43M
--19.66M
Operating profit
-21.06%-26.50M
-14.55%-21.94M
-19.86%-21.07M
-258.54%-21.81M
-63.99%-21.89M
46.25%-19.15M
-34.52%-17.57M
173.81%13.76M
27.38%-13.35M
-319.40%-35.63M
-717.07%-13.06M
-234.47%-18.64M
-270.62%-18.38M
-308.34%-8.50M
18.79%-1.60M
2966.37%13.86M
250.50%10.77M
151.63%4.08M
85.66%-1.97M
102.76%452.00K
Net Profit
-121.24%-39.18M
-802.92%-92.58M
-48.46%-35.90M
37.70%13.26M
68.83%-17.71M
94.23%-10.25M
-168.64%-24.18M
184.55%9.63M
-162.31%-56.82M
-3114.73%-177.66M
-14.05%-9.00M
-232.39%-11.39M
-175.28%-21.66M
-51.85%5.89M
55.89%-7.89M
88.41%8.60M
217.00%28.78M
179.24%12.24M
-83.92%-17.89M
118.96%4.56M
Current assets
-34.08%122.04M
-40.32%129.28M
-35.73%147.26M
30.94%163.40M
66.61%185.12M
138.76%216.63M
154.97%229.14M
1.68%124.78M
-19.71%111.11M
-38.75%90.73M
-43.72%89.87M
-28.88%122.72M
6.45%138.39M
2.56%148.14M
5.21%159.68M
3.45%172.57M
-20.30%130.01M
-4.56%144.44M
-8.85%151.77M
173.23%166.81M
Total current liabilities
6.31%15.95M
-34.99%14.94M
-35.52%13.80M
-53.07%12.26M
-59.08%15.00M
-66.32%22.98M
7.35%21.41M
-11.07%26.11M
38.16%36.65M
172.00%68.21M
-15.97%19.94M
-13.02%29.37M
-32.40%26.53M
-65.29%25.08M
-75.18%23.73M
-61.32%33.76M
-53.61%39.25M
-11.40%72.25M
24.17%95.62M
287.81%87.30M
Total assets
-29.51%288.39M
-31.86%296.41M
-18.15%372.68M
11.84%388.89M
25.81%409.13M
42.61%435.02M
329.41%455.32M
149.26%347.74M
108.88%325.21M
83.89%305.05M
-40.52%106.03M
-25.82%139.51M
6.86%155.69M
3.75%165.89M
6.64%178.26M
4.18%188.07M
-17.57%145.70M
-3.36%159.88M
-7.64%167.16M
140.04%180.52M
Total liabilities
1.30%436.51M
-4.34%422.65M
-10.13%408.52M
-12.86%391.42M
-2.51%430.92M
-0.64%441.82M
894.56%454.56M
506.55%449.20M
444.92%442.01M
517.11%444.68M
-51.04%45.70M
-24.79%74.06M
-9.81%81.11M
-47.54%72.06M
-49.78%93.36M
-46.70%98.46M
-54.19%89.93M
-25.12%137.36M
-1.32%185.89M
109.32%184.74M
Total equity
-579.78%-148.12M
-1755.92%-126.24M
-4866.49%-35.84M
97.51%-2.53M
81.35%-21.79M
95.13%-6.80M
-98.75%752.00K
-255.02%-101.46M
-256.61%-116.80M
-248.81%-139.63M
-28.95%60.33M
-26.96%65.45M
33.74%74.58M
316.62%93.83M
553.30%84.91M
2222.36%89.61M
384.93%55.76M
225.07%22.52M
-153.74%-18.73M
67.65%-4.22M
Net operating income
4.21%-22.14M
-152.96%-17.71M
-213.94%-15.60M
-21.29%-17.52M
-45.18%-23.11M
69.93%-7.00M
248.57%13.69M
-45.99%-14.45M
-81.60%-15.92M
-96.52%-23.29M
-311.69%-9.21M
19.36%-9.89M
26.12%-8.77M
62.34%-11.85M
140.51%4.35M
-103.06%-12.27M
2.22%-11.86M
-333.93%-31.46M
-116.37%-10.75M
48.82%-6.04M
Net investment
97.49%-27.00K
-38.98%-492.00K
79.16%-1.29M
-63.52%-2.60M
-78.57%-1.07M
-105.45%-354.00K
---6.20M
-13125.00%-1.59M
-102.14%-602.00K
18.36%6.50M
100.00%0.00
87.88%-12.00K
194.65%28.12M
-43.54%5.49M
-1561.32%-29.94M
96.21%-99.00K
142.53%9.54M
5956.63%9.72M
-530.07%-1.80M
-1598.05%-2.62M
Net financing
295.28%15.67M
-106.64%-52.00K
-100.03%-38.00K
-50.00%60.00K
-118.65%-8.03M
-94.44%783.00K
602.21%124.49M
104.64%120.00K
28779.87%43.03M
--14.08M
-4150.49%-24.79M
-107.01%-2.59M
-91.38%149.00K
-100.00%0.00
-57.79%612.00K
310.45%36.88M
-91.89%1.73M
11234.74%21.16M
-93.08%1.45M
1038.77%8.98M

FAQs

What is the total revenue of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its total revenue reached 2.80M, with a year-on-year change of 38.91M.

What are the current assets of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its current assets were 129.28M, with a year-on-year change of -40.32.

What are the total assets of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its total assets of Cartesian Therapeutics Inc were 296.41M, with a year-on-year change of -31.86.

What are the total liabilities of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its total liabilities of Cartesian Therapeutics Inc were 422.65M, with a year-on-year change of -4.34.

What is the total equity of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its total equity of Cartesian Therapeutics Inc was -126.24M, with a year-on-year change of -1755.92.

What is the net operating income of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its net operating income of Cartesian Therapeutics Inc was -86.70M, with a year-on-year change of -138.74.

What is the net investment of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its net investment of Cartesian Therapeutics Inc was -5.45M, with a year-on-year change of 37.61.

What is the net financing of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its net financing of Cartesian Therapeutics Inc was -8.05M, with a year-on-year change of -104.78.

What is the Earnings Per Share (EPS) of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its Earnings Per Share (EPS) was -5.02, with a year-on-year change of -11.95.

What is the net income of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its net income was -130.30M, with a year-on-year change of -68.30.

What is the net margin of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its net profit margin was -4658.63, with a year-on-year change of -2241.41.

What is the Return on Assets (ROA) of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its Return on Assets (ROA) was -35.63, with a year-on-year change of -70.28.

What is the operating profit of Cartesian Therapeutics Inc?

According to Cartesian Therapeutics Inc's FY2025 earnings report, its operating profit was -86.70M, with a year-on-year change of -138.74.
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.